Overview

Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

Status:
Completed

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

This is a study to evaluate the primovist as a new contrast agent useful to diagnostic of hepatocellular carcinoma

Phase:

Phase 4

Details

Lead Sponsor:

Sara Varea